Neurocrine Biosciences, Inc.
Neurocrine Biosciences discovers and develops drugs for the treatment of neurological and endocrine-related diseases and disorders. The company's product candidates address pharmaceutical markets in the world, including insomnia, anxiety, depression, various female and male health disorders, diabetes, and other neurological and endocrine related diseases and disorders. The company has nine programs in various stages of research and development, including seven programs in clinical development. While the company independently develops many of its product candidates, it has entered into collaborations for one of its programs.